AngiostatinYIHAI CAO; LEXUN XUE.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 1, pp 83-93, issn 0094-6176, 11 p.Article

Generation and role of angiostatin in human plateletsJURASZ, Paul; ALONSO, David; CASTRO-BLANCO, Susana et al.Blood. 2003, Vol 102, Num 9, pp 3217-3223, issn 0006-4971, 7 p.Article

Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection methodKEUN SIK KIM; YONG SERK PARK.Oncology research. 2005, Vol 15, Num 7-8, pp 343-350, issn 0965-0407, 8 p.Article

Low levels of endostatin in the urine from patients with malignant diseaseLINDER-STRAGLIOTTO, Christina; STRANDER, Hans; MUNCK-WIKLAND, Eva et al.Tumor biology. 2002, Vol 23, Num 4, pp 222-227, issn 1010-4283, 6 p.Article

Angiostatin production in cultivation of recombinant Pichia pastoris fed with mixed carbon sourcesJINGLI XIE; LI ZHANG; QIN YE et al.Biotechnology letters. 2003, Vol 25, Num 2, pp 173-177, issn 0141-5492, 5 p.Article

Soluble tissue factor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domainsALBRECHT, Sybille; MAGDOLEN, Viktor; HERZOG, Ute et al.Thrombosis and haemostasis. 2002, Vol 88, Num 6, pp 1054-1059, issn 0340-6245, 6 p.Article

Angiogenic targets for potential disordersBHADADA, Shraddha V; GOYAL, Bhoomika R; PATEL, Mayur M et al.Fundamental & clinical pharmacology. 2011, Vol 25, Num 1, pp 29-47, issn 0767-3981, 19 p.Article

Anti-angiogenesis mediated by angiostatin KI-3, KI-4 and KI-4.5 : Involvement of p53, Fasl, AKT and mRNA deregulationCHEN, Ya-Huey; WU, Hua-Lin; CHING LI et al.Thrombosis and haemostasis. 2006, Vol 95, Num 4, pp 668-677, issn 0340-6245, 10 p.Article

Expression of angiostatin, integrin αvβ3, and vitronectin in human lungs in sepsisSINGH, Baljit; JANARDHAN, Kyathanahalli S; KANTHAN, Rani et al.Experimental lung research. 2005, Vol 31, Num 8, pp 771-782, issn 0190-2148, 12 p.Article

Nicked β2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic propertyNAKAGAWA, Hisako; YASUDA, Shinsuke; MATSUURA, Eiji et al.Blood. 2009, Vol 114, Num 12, pp 2553-2559, issn 0006-4971, 7 p.Article

Therapeutic potentials of angiostatin in the treatment of cancerYIHAI CAO.Haematologica - Journal of hematology. 1999, Vol 84, Num 7, pp 643-650Article

Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F₁F₀ ATP synthaseCHI, Sulene L; WAHL, Miriam L; CAPALDI, Roderick A et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4716-4724, issn 0008-5472, 9 p.Article

Platelet-associated angiogenesis regulating factors: a pharmacological perspectiveRADZIWON-BALICKA, Aneta; MONCADA DE LA ROSA, Cesar; JURASZ, Paul et al.Canadian journal of physiology and pharmacology. 2012, Vol 90, Num 6, pp 679-688, issn 0008-4212, 10 p.Conference Paper

Thrombophilic-Type Placental Pathologies and Skeletal Growth Delay Following Maternal Administration of Angiostatin_4.5 in MiceRUTLAND, CatrinS; ATKINSON, SarahD; MUKHOPADHYAY, Mallinath et al.Biology of reproduction. 2011, Vol 84, Num 3, pp 505-513, issn 0006-3363, 9 p.Article

MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failureGIVVIMANI, Srikanth; TYAGI, Neetu; SEN, Utpal et al.Archives of physiology and biochemistry. 2010, Vol 116, Num 2, pp 63-72, issn 1381-3455, 10 p.Article

Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy modelIGARASHI, Tsutomu; MIYAKE, Koichi; KATO, Ko et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 3, pp 219-226, issn 0969-7128, 8 p.Article

Isolation and characterization of human thyroid endothelial cellsPATEL, Vimal A; LOGAN, Ann; WATKINSON, John C et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 47, Num 1, pp 168-176, issn 0193-1849, 9 p.Article

Pneumococcal phosphoglycerate kinase interacts with plasminogen and its tissue activatorFULDE, Marcus; BERNARDO-GARCIA, Noelia; BERGMANN, Simone et al.Thrombosis and haemostasis. 2014, Vol 111, Num 3, pp 401-416, issn 0340-6245, 16 p.Article

Elevated levels of angiostatin in effusions from patients with malignant diseaseROTENBERG, Rosa G; ROZAS, Natalia S; GUERRI, Lucia et al.Oncology reports. 2004, Vol 11, Num 2, pp 523-528, issn 1021-335X, 6 p.Article

Angiostatin expression in ovarian cancerYABUSHITA, Hiromitsu; NOGUCHI, Mari; OBAYASHI, Yukihiko et al.Oncology reports. 2003, Vol 10, Num 5, pp 1225-1230, issn 1021-335X, 6 p.Article

The Role of Annexin II in Angiogenesis and Tumor Progression : A Potential Therapeutic Target : Angiogenesis agentsSHARMA, Mahesh C; SHARMA, Meena.Current pharmaceutical design. 2007, Vol 13, Num 35, pp 3568-3575, issn 1381-6128, 8 p.Article

Angiostatin receptor annexin II in vascular tumors including angiosarcomaSYED, Sajjad P; MARTIN, Anne-Marie; HAUPT, Helen M et al.Human pathology. 2007, Vol 38, Num 3, pp 508-513, issn 0046-8177, 6 p.Article

Differential binding of plasminogen, plasmin, and angiostatin4.5 to cell surface β-actin : Implications for cancer-mediated angiogenesisHAO WANG; DOLL, Jennifer A; KEYI JIANG et al.Cancer research (Baltimore). 2006, Vol 66, Num 14, pp 7211-7215, issn 0008-5472, 5 p.Article

Angiostatin inhibits extracellular HIV-tat-induced inflammatory angiogenesisBENELLI, Roberto; MORINI, Monica; BRIGATI, Claudio et al.International journal of oncology. 2002, Vol 22, Num 1, pp 87-91, issn 1019-6439, 5 p.Article

Cyclooxygenase-2 overexpression inhibits cathepsin D-mediated cleavage of plasminogen to the potent antiangiogenic factor angiostatinPERCHICK, Gabrielle B; JABBOUR, Henry N.Endocrinology (Philadelphia). 2003, Vol 144, Num 12, pp 5322-5328, issn 0013-7227, 7 p.Article